I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

MLYS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.24%

Insider Buying (Last 12 Months): $7,499,992.50

Insider Selling (Last 12 Months): $9,941,749.06

Mineralys Therapeutics Insider Trading History Chart

Mineralys Therapeutics Share Price & Price History

^$12.97

▲ +0.48 (3.84%)

As of 11/25/2024 05:25 PM ET

Days: 30 | 90 | 365

Financial Prophecy

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Mineralys Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2024	David Malcom Rodman	Insider	Sell	25,482	$15.03	$382,994.46	135,974
10/11/2024	Adam Scott Levy	CFO	Sell	10,757	$13.57	$145,972.49	236,854
10/11/2024	Jon Congleton	CEO	Sell	15,271	$13.52	$206,463.92	895,941
7/24/2024	Brian Taylor Slingsby	Director	Sell	550,000	$13.05	$7,177,500.00	8,644,579
7/16/2024	David Malcom Rodman	Insider	Sell	525	$15.00	$7,875.00	102,873
7/11/2024	Adam Scott Levy	CFO	Sell	10,757	$13.14	$141,346.98	247,611
7/11/2024	Jon Congleton	CEO	Sell	15,746	$13.34	$210,051.64	911,212
6/14/2024	Jon Congleton	CEO	Sell	16,229	$12.52	$203,187.08	976,271
6/12/2024	Jon Congleton	CEO	Sell	16,607	$12.77	$212,071.39	1,032,461
6/11/2024	Adam Scott Levy	CFO	Sell	96,815	$12.94	$1,252,786.10	255,462
5/9/2024	David Malcom Rodman	Insider	Sell	100	$15.00	$1,500.00	66,997
2/12/2024	Samsara Biocapital Gp, Llc	Major Shareholder	Buy	555,555	$13.50	$7,499,992.50	5,074,916
11/22/2023	Jon Congleton	CEO	Buy	4,250	$5.97	$25,372.50	1,049,068
9/6/2023	Jon Congleton	CEO	Buy	2,250	$12.08	$27,180.00	1,044,818
8/17/2023	Jon Congleton	CEO	Buy	2,250	$12.10	$27,225.00	1,042,568
8/11/2023	David Malcom Rodman	insider	Sell	157,091	$12.81	$2,012,335.71
8/11/2023	Jon Congleton	CEO	Buy	2,000	$12.89	$25,780.00	1,040,318
2/14/2023	Adam Scott Levy	CFO	Buy	6,250	$16.00	$100,000.00	350,811
2/14/2023	Hbm Healthcare Investments (Ca	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00	3,218,106
2/14/2023	Ra Capital Management, L.P.	Director	Buy	1,250,000	$16.00	$20,000,000.00	1,867,229

Financial Prophecy

From Porter & Company | Ad

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Mineralys Therapeutics (NASDAQ:MLYS)

84.46% of Mineralys Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mineralys Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	38,218	$0.46M	0.0%	+281.8%	0.077%
11/16/2024	Geode Capital Management LLC	620,853	$7.52M	0.0%	+6.6%	1.247%
11/15/2024	Barclays PLC	38,218	$0.46M	0.0%	+281.8%	0.077%
11/15/2024	Jane Street Group LLC	15,855	$0.19M	0.0%	-30.4%	0.032%
11/15/2024	Wellington Management Group LLP	63,998	$0.78M	0.0%	N/A	0.129%
11/15/2024	Sphera Funds Management LTD.	272,472	$3.30M	0.5%	-38.5%	0.547%
11/15/2024	State Street Corp	483,766	$5.86M	0.0%	+4.0%	0.972%
11/15/2024	Polar Asset Management Partners Inc.	40,500	$0.49M	0.0%	N/A	0.081%
11/15/2024	Ikarian Capital LLC	180,000	$2.18M	0.3%	N/A	0.362%
11/14/2024	Bellevue Group AG	16,499	$0.20M	0.0%	-5.7%	0.033%
11/14/2024	Caligan Partners LP	981,155	$11.88M	3.8%	+31.6%	1.973%
11/14/2024	PDT Partners LLC	12,238	$0.15M	0.0%	N/A	0.025%
11/14/2024	Verition Fund Management LLC	27,361	$0.33M	0.0%	+30.6%	0.055%
11/14/2024	Martingale Asset Management L P	14,965	$0.18M	0.0%	N/A	0.030%
11/13/2024	FMR LLC	303,758	$3.68M	0.0%	+12.0%	0.611%
11/12/2024	Charles Schwab Investment Management Inc.	213,599	$2.59M	0.0%	+4.7%	0.430%
11/8/2024	Jennison Associates LLC	696,280	$8.43M	0.0%	+1.9%	1.400%
10/25/2024	China Universal Asset Management Co. Ltd.	9,564	$0.12M	0.0%	+64.0%	0.019%
10/3/2024	SG Americas Securities LLC	9,116	$0.11M	0.0%	N/A	0.018%
8/20/2024	Nantahala Capital Management LLC	532,506	$6.23M	0.4%	+60.1%	1.073%
8/16/2024	Driehaus Capital Management LLC	257,371	$3.01M	0.0%	+40.4%	0.518%
8/15/2024	Blue Owl Capital Holdings LP	450,339	$5.27M	1.5%	-16.8%	0.907%
8/15/2024	Lion Point Capital LP	79,000	$0.92M	1.7%	+31.7%	0.159%
8/15/2024	The Manufacturers Life Insurance Company	12,432	$0.15M	0.0%	N/A	0.025%
8/14/2024	Adams Street Partners LLC	1,688,712	$19.76M	8.1%	-10.0%	3.401%
8/9/2024	Renaissance Technologies LLC	61,800	$0.72M	0.0%	+95.0%	0.124%
8/8/2024	Federated Hermes Inc.	12,000	$0.14M	0.0%	+100.0%	0.024%
8/8/2024	American Century Companies Inc.	743,140	$8.70M	0.0%	+3.2%	1.497%
8/1/2024	Rhumbline Advisers	41,079	$0.48M	0.0%	+82.1%	0.083%
7/26/2024	Bank of New York Mellon Corp	84,762	$0.99M	0.0%	+72.5%	0.171%
5/17/2024	RA Capital Management L.P.	4,850,984	$62.63M	0.8%	+52.6%	9.770%
5/16/2024	California State Teachers Retirement System	1,953	$25K	0.0%	-38.9%	0.004%
5/15/2024	Bellevue Group AG	9,200	$0.12M	0.0%	N/A	0.019%
5/15/2024	Affinity Asset Advisors LLC	327,959	$4.23M	0.5%	N/A	0.661%
5/14/2024	EntryPoint Capital LLC	4,632	$60K	0.1%	-30.4%	0.009%
5/14/2024	SR One Capital Management LP	2,016,822	$26.04M	7.2%	+12.4%	4.062%
5/10/2024	Vanguard Group Inc.	982,932	$12.69M	0.0%	+0.5%	1.980%
4/29/2024	China Universal Asset Management Co. Ltd.	7,931	$0.10M	0.0%	+67.0%	0.016%
3/22/2024	PNC Financial Services Group Inc.	4,122	$35K	0.0%	+17,821.7%	0.010%
2/14/2024	Catalys Pacific LLC	9,194,579	$79.07M	74.1%	N/A	22.371%
2/14/2024	Pale Fire Capital SE	34,743	$0.30M	0.0%	N/A	0.085%
2/14/2024	Sectoral Asset Management Inc.	605,606	$5.21M	2.2%	-28.0%	1.473%
2/13/2024	Tower Research Capital LLC TRC	2,879	$25K	0.0%	-71.4%	0.007%
2/13/2024	NEOS Investment Management LLC	23,973	$0.21M	0.0%	N/A	0.058%
2/9/2024	Franklin Resources Inc.	699,467	$6.02M	0.0%	+55.4%	1.702%
2/9/2024	CreativeOne Wealth LLC	10,750	$92K	0.0%	N/A	0.026%
2/7/2024	Jump Financial LLC	20,500	$0.18M	0.0%	-37.3%	0.050%
2/5/2024	Russell Investments Group Ltd.	5,779	$50K	0.0%	-43.2%	0.014%
2/1/2024	CWM LLC	5,891	$51K	0.0%	+120.0%	0.014%
1/31/2024	Federated Hermes Inc.	20,032	$0.17M	0.0%	-10.1%	0.049%
1/30/2024	Cornercap Investment Counsel Inc.	22,209	$0.19M	0.0%	N/A	0.054%
1/24/2024	China Universal Asset Management Co. Ltd.	4,750	$41K	0.0%	N/A	0.012%
1/16/2024	Raymond James Financial Services Advisors Inc.	14,611	$0.13M	0.0%	-64.0%	0.036%
1/12/2024	SG Americas Securities LLC	10,093	$87K	0.0%	N/A	0.025%
11/15/2023	Sectoral Asset Management Inc.	840,759	$8M	1.6%	+36.8%	2.046%
11/15/2023	Laurion Capital Management LP	969,978	$9.22M	0.1%	+42.6%	2.360%
11/14/2023	Braidwell LP	2,023,900	$19.25M	0.6%	+267.8%	4.924%
11/14/2023	Schonfeld Strategic Advisors LLC	192,362	$1.83M	0.0%	+64.3%	0.468%
11/13/2023	CHI Advisors LLC	568,379	$5.41M	1.6%	N/A	1.383%
11/13/2023	Federated Hermes Inc.	22,293	$0.21M	0.0%	+8.3%	0.054%
11/13/2023	FMR LLC	1,188,653	$11.30M	0.0%	+62.6%	2.892%
11/7/2023	Jump Financial LLC	32,700	$0.31M	0.0%	N/A	0.080%
10/24/2023	Raymond James Financial Services Advisors Inc.	40,578	$0.39M	0.0%	N/A	0.099%
10/11/2023	CWM LLC	2,678	$25K	0.0%	N/A	0.007%
9/21/2023	Barclays PLC	2,778	$47K	0.0%	-77.8%	0.007%
8/15/2023	Sphera Funds Management LTD.	405,400	$6.91M	1.1%	+19.6%	0.992%
8/14/2023	Great Point Partners LLC	546,059	$9.31M	1.8%	-12.0%	1.336%
8/14/2023	Driehaus Capital Management LLC	499,983	$8.53M	0.1%	+10.4%	1.224%
8/11/2023	Panagora Asset Management Inc.	23,016	$0.39M	0.0%	N/A	0.056%
8/11/2023	Sectoral Asset Management Inc.	614,713	$10.48M	1.7%	+0.2%	1.504%
8/11/2023	ExodusPoint Capital Management LP	193,525	$3.30M	0.0%	+6.7%	0.474%
8/10/2023	Letko Brosseau & Associates Inc.	11,400	$0.19M	0.0%	N/A	0.028%
8/4/2023	American International Group Inc.	6,717	$0.12M	0.0%	+15.0%	0.016%
8/2/2023	Bank of Montreal Can	101,724	$1.51M	0.0%	N/A	0.249%
5/19/2023	SR One Capital Management LP	1,794,600	$28.10M	9.5%	N/A	4.392%
5/16/2023	Great Point Partners LLC	620,326	$9.71M	1.9%	N/A	1.518%
5/16/2023	Ghisallo Capital Management LLC	10,000	$0.16M	0.0%	N/A	0.024%
5/15/2023	Affinity Asset Advisors LLC	62,500	$0.98M	0.3%	N/A	0.153%
5/15/2023	Logos Global Management LP	300,000	$4.70M	0.7%	N/A	0.734%
5/15/2023	RTW Investments LP	922,100	$14.44M	0.3%	N/A	2.257%
5/12/2023	Sectoral Asset Management Inc.	613,233	$9.60M	1.8%	N/A	1.501%
5/11/2023	ExodusPoint Capital Management LP	181,312	$2.84M	0.0%	N/A	0.444%
5/11/2023	American Century Companies Inc.	417,903	$6.53M	0.0%	N/A	1.023%
5/5/2023	Monashee Investment Management LLC	110,000	$1.72M	0.5%	N/A	0.269%
4/27/2023	Strs Ohio	2,500	$39K	0.0%	N/A	0.006%

Data available starting January 2016

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $12.97

$12.70

$13.00

50 Day Range

MA: $13.05

$11.40

$14.95

52 Week Range

Now: $12.97

$6.12

$16.91

Volume

10,278 shs

Average Volume

179,628 shs

Market Capitalization

$645.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.71

Who are the company insiders with the largest holdings of Mineralys Therapeutics?: Mineralys Therapeutics' top insider shareholders include:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Hbm Healthcare Investments (Ca (Major Shareholder)
Ra Capital Management, LP (Director)
Jon Congleton (CEO)
Adam Scott Levy (CFO)
David Malcom Rodman (Insider)
Learn More about top insider investors at Mineralys Therapeutics.
Who are the major institutional investors of Mineralys Therapeutics?: Mineralys Therapeutics' top institutional investors include:
Caligan Partners LP — 1.97%
Jennison Associates LLC — 1.40%
Geode Capital Management LLC — 1.25%
State Street Corp — 0.97%
FMR LLC — 0.61%
Sphera Funds Management LTD. — 0.55%
Learn More about top institutional investors of Mineralys Therapeutics stock.
Which major investors are selling Mineralys Therapeutics stock?: In the previous quarter, MLYS stock was sold by these institutional investors:
Sphera Funds Management LTD.
Jane Street Group LLC
Bellevue Group AG
In the last year, company insiders that have sold Mineralys Therapeutics company stock include:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Hbm Healthcare Investments (Ca (Major Shareholder)
Ra Capital Management, LP (Director)
Learn More investors selling Mineralys Therapeutics stock.
Which major investors are buying Mineralys Therapeutics stock?: During the last quarter, MLYS stock was purchased by institutional investors including:
Caligan Partners LP
Ikarian Capital LLC
Wellington Management Group LLP
Polar Asset Management Partners Inc.
Geode Capital Management LLC
FMR LLC
Barclays PLC
Barclays PLC
In the previous year, these company insiders have bought Mineralys Therapeutics stock:
Brian Taylor Slingsby (Director)
Samsara Biocapital Gp, Llc (Major Shareholder)
Hbm Healthcare Investments (Ca (Major Shareholder)
Ra Capital Management, LP (Director)
Jon Congleton (CEO)
Learn More investors buying Mineralys Therapeutics stock.